The European University Hospital Alliance is formed by leading European university hospitals with demonstrated excellence in healthcare, education and research.
To support this EUHA has formulated the following mission statement:
The European University Hospital Alliance (EUHA) is a close network that consists of some of Europe’s leading university hospitals that have a strong track record of excellence in tertiary care, research and education.
In particular they:
EUHA aims to expand its membership, but remain a close cooperation between excellent university hospitals. Therefore, EUHA will bi-annually invite one or a few leading European University Hospitals to complement its membership. This process is led by the Member’s Assembly and executed by the Steering Committee.
Vall d’Hebron Barcelona Hospital Campus is a world-class healthcare park where assistance, research, teaching and innovation go hand in hand. We are the sum of five institutions: Vall d’Hebron University Hospital, Vall d’Hebron Research Institute, Vall d’Hebron Institute of Oncology, the Multiple Sclerosis Center of Catalonia and the Autonomous University of Barcelona. We work together with the same pioneering spirit and a common goal: to improve the health and well-being of people.
The Vall d’Hebron University Hospital is the largest tertiary hospital group in Catalonia and one of the largest in Spain. We offer high-complexity healthcare from birth to old age.
Charité – Universitätsmedizin Berlin is one of the largest university hospitals in Europe, boasting 3,099 beds and approximately 100 departments and institutes spread across 4 separate campuses. At Charité, the areas of research, teaching and medical care are closely interlinked. With a total of 20,921 members of staff employed across its group of companies (17,615 of which at Charité), the organization is one of the largest employers in Berlin. 5,047 of its employees work in the field of nursing, with a further 4,988 in research and medical care. Last year, Charité treated 123,793 in- and day case patients, in addition to 682,731 outpatients. In 2021, Charité recorded a turnover of approximately € 2.3 billion (including external funding and investment grants) and set a new record by securing more than € 215.8 million in external funding.
Charité’s Medical Faculty is one of the largest in Germany, educating and training more than 9,000 students across the subjects of medicine, dentistry, health sciences and nursing. Charité also offers 730 training positions across 11 different health care professions, in addition to 111 training positions in a further 8 professions. Within the field of academic medicine, Charité’s priorities are highlighted by its main areas of research focus: infection; inflammation and immunity including COVID-19 research; cardiovascular research and metabolism; neuroscience; oncology; regenerative therapies; and rare diseases and genetics. Examples of the work conducted by Charité researchers include involvement in 28 DFG Collaborative Research Centers (of which seven are led by Charité), three Clusters of Excellence (of which one is led by Charité), 10 Emmy Noether Independent Junior Research Groups, 14 European Research Council grants and 8 European collaborative projects (coordinated by Charité).
Helsinki University Hospital is the largest healthcare provider in Finland. We are responsible for organizing specialized healthcare in the southern part of Finland, including the capital region. In addition, the treatment of many rare and severe diseases is nationally centralized to HUS. Our expertise is internationally recognized and accredited, and as a university hospital, we continuously develop and evaluate our treatment methods and activities. Together with the University of Helsinki, we form one of the most active clusters of research and education in Europe. The symbiosis between these two organizations enables the integration of research, education, and healthcare. Many researchers at HUS also hold positions at the University and vice versa, and we participate in numerous EU-funded research and development projects.
Annually, we at HUS treat 700,000 patients with 27,500 professionals, achieving high patient satisfaction with an NPS score. We have approximately 2.4 million outpatient clinic visits and perform 83,000 surgical procedures. Our specialist medical care emergency clinics handle an average of 700 visits per day, and in our hospitals, approximately 475 organ transplants and 15,300 childbirths are carried out yearly. We operate in 21 hospitals and have activities in hundreds of smaller locations for outpatient care and diagnostics.
At HUS, we pioneer in working for public healthcare and strive to ensure the functioning and improvement of specialized medical care in Finland. We are dedicated to contributing to the Finnish social and healthcare reform, which started in 2023, aiming to achieve an optimal level of integration of services with primary care. The size and scope of our operations oblige us to take responsibility in acting as pioneers within our sector, both in Finland and internationally. We guarantee care in the most demanding cases where no one else can.
AP-HP (Greater Paris University Hospitals) is a European world-renowned university hospital system. Its 39 hospitals treat 10 million people annually in consultation, emergency, and during scheduled or at-home hospitalizations. The AP-HP provides a public health service for everyone, 24 hours a day. This public mission is a duty as well as a great source of pride. AP-HP is the leading employer in the Greater Paris area employing nearly 100 000 staff members – doctors, researchers, paramedical staff, administrative personnel and workers. AP-HP is formed by 39 hospitals now organised in 6 groups of hospitals and 81 medical university departments (DMU), over 800 medical departments, with 5 universities.
With an annual budget of 7,8 billion euros*, AP-HP has 20,000 beds, 326 operating rooms, 25 emergency departments (17 for adults, 8 for pediatric care), 13 maternity units (37,000 births annually) and 1,4 emergency unit admissions per year. AP-HP ranks first for clinical research in Europe, with 10,200 scientific publications per year and over 3,500 sponsored research projects in progress.
*annual report 2020
Erasmus MC is a University Medical Center that combines medical, nursing and post-graduate schools, biomedical research facilities, tertiary care and teaching hospital and a general hospital. Erasmus MC research stretches from biomedical to patient and population-based research. The institute has 4.500 (bio) medical students, 16.500 employees and an annual budget of approximately 1.7 billion euros. It is the largest university medical centre in the Netherlands.
The institute aims to further expand its international activities in the coming years, both in terms of patient care and education, while already being strongly internationally oriented in research. Erasmus MC has 60 designated centres of expertise for rare diseases, approved by the Dutch government and 18 of them are involved in European Reference Networks as members, coordinators or sub-coordinators. The strategy of the Erasmus MC is to expand on tertiary and complex acute care, among others by creating a network with other hospitals.
Karolinska University Hospital is one of the largest university hospitals in Europe. We have a triple assignment of healthcare, research, and education, and a guiding vision – “Patient first”. We work closely with the Karolinska Institute, providing training and conducting world-class medical research in many different fields. Together, we are the hub of an academic healthcare system generating new and improved medical outcomes and accelerating the time to patient access of the benefits they bring.
Karolinska University Hospital is committed to and involved in a wide range of medical research that not only enhances and improves our existing knowledge, but also forms the basis for future health and medical care. Karolinska University Hospital’s new hospital building in Solna is one of the largest ever investments made in health and medical care in Sweden. The new facilities will also optimize the expertise and equipment at our disposal, enhancing our ability to take care of the most severely injured and seriously ill patients.
King’s Health Partners (KHP) is an Academic Health Sciences Centre where world-class research, education and clinical practice are brought together for the benefit of patients. KHP brings together three NHS Foundation Trusts with a world-leading university for health research and education. With nearly 4.8 million patient contacts each year, 46,000 staff and nearly 31,000 students and a combined annual turnover of more than £4.2 billion, KHP provides services across central and outer London locations, including seven mental health and physical healthcare hospitals and many community sites.
King’s College London is ranked in the top 25 research universities in the world. It is the largest centre for healthcare education in Europe and provides education and research in the widest range of subjects allied to medicine of any London institution.
Our three NHS founders; Guy’s and St Thomas’, King’s College Hospital and South London and Maudsley NHS Foundation Trusts, serve a local population which is among the most ethnically, socially and economically diverse in the world. Together they provide a full range of medical and healthcare services, from acute and specialist medical care, local and highly specialised mental healthcare, and services that promote physical and psychological wellbeing.
IRCCS Ospedale San Raffaele is a university and research hospital established in 1971, capable of offering specialized care for the most complex medical conditions. In 1972, the hospital was officially recognized as a research hospital (Istituto di Ricovero e Cura a Carattere Scientifico, IRCCS), and in 2012 it became part of Gruppo San Donato.
With over 60 clinical units and 100 research laboratories, IRCCS Ospedale San Raffaele combines both clinical and scientific activities through a translational approach whereby discoveries made in the laboratory inform clinical practice and research is driven by clinical needs.
The institute aims at understanding the mechanisms underlying a variety of human diseases and at identifying new therapeutic strategies to treat them. Alongside with improving therapies, the institute aims to develop new technologies in the field of genomics and imaging, essential for supporting early diagnosis and increasingly personalized medicine. Among the principal clinical areas of investigation are central and peripheral nervous systems pathologies, tumours, immune-mediated, infectious, genetic, cardiovascular and metabolic diseases. The institute is recognized as a global authority in cell and gene therapies.
The University Hospital Vienna (AKH Vienna) and the Medical University of Vienna (MedUni Vienna), two outstanding institutions are concentrated in one location. The University Hospital Vienna is ranked among the best hospitals in the world. The Medical University of Vienna is one of the most longstanding medical training and research facilities in Europe. Together, the two institutions fulfil three core tasks: Patient care, research and teaching. At 29 clinical departments with over 400 specialized outpatient departments, a broad spectrum of medical expertise is available. New therapies are constantly being established and implemented in numerous highly specialized departments.
The AKH Vienna and the MedUni Vienna form together the largest and most important medical care centre in Austria in which more than 60,000 patients are treated annually as in-patients. The out-patient and special out-patient wards are frequented by around 1.2 million people. Each year, around 45,000 operations are carried out at the University Hospital Vienna. With almost 8,000 students, MedUni Vienna is currently the largest medical training centre in German-speaking countries.
As the largest university hospital in Belgium, UZ Leuven wants to break new ground by combining specialised care and innovative treatments with personal attention and respect for every patient. More than 10, 000 passionate employees provide the best personalised care every day. Future care providers and employees receive high-quality training at UZ Leuven, with a view to lifelong learning and innovation. A pioneer in clinical trials, the hospital also invests in the patient care of tomorrow
Through constant investment in research, new treatments and the latest technology, UZ Leuven is among the Belgian and international top in many disciplines. Patients with the most complex conditions come to UZ Leuven. The hospital is renowned worldwide for transplants, foetal surgery, the centre for human genetics, and hereditary diseases and has the first Belgian proton therapy centre for cancer treatments and investigation. The hospital is located on the Gasthuisberg Health Sciences campus, where hospital physicians and university researchers work within walking distance from one another. The combination of clinical care, research and education in a single location creates an inspiring interaction that, ultimately, always has one goal in mind: better patient care.
Aarhus University Hospital (AUH) develops and provides highly specialised treatment, research, and education that is driven by three core values: dialogue, competence and boldness. This state-of-the-art Danish teaching hospital consists of 53 departments, employing more than 10,000 full-time staff and performing over 82,000 surgeries per year. The hospital provides specialised treatment to people from all over Denmark, and local treatment to residents of Aarhus, with annual outpatient visits approaching 1 million per year.
The hospital is considered to be among the elite of university hospitals and at the forefront of healthcare innovation, playing an active role in the development of healthcare services regionally, nationally and internationally while working closely together with Aarhus University.
AUH ranks in the top three best smart hospitals in Europe and is the sixteenth best hospital in the world according to the American magazine Newsweek. The hospital is a pioneer in the use of logistics data and patient-empowering initiatives like Patient Reported Outcomes (PROs), an online service that helps the hospital’s clinicians provide higher standards of care to more than 22,000 patients with chronic diseases. AUH also hosts the Danish Centre for Particle Therapy and is a member of nineteen European Reference Networks for rare diseases.
The EUHA Office drives and coordinates alliance activities, manages communication, and coordinates the development of broader stakeholder relations and policy advice at the European level. At the moment, the Office is formed by EUHA Secretary-General, Johan Van Eldere, Alliance Manager, Lynn Seveke, and Project and Communications Officer, Martina Garriga.
The Office and Steering Committee consist of the following people:
The European University Hospital Alliance is registered as a not-for profit international association (IVZW/AISBL). Number 0772.718.430, EUHA’s seat is at Warmoesberg 26, 1000 Brussels, Belgium.